Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6,940 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Rivaroxaban Treatment for Patients With Unprovoked or Provoked Venous Thromboembolism　- Subanalysis of the J'xactly Study.
Hisatake S, Ikeda T, Fukuda I, Nakamura M, Yamada N, Takayama M, Maeda H, Yamashita T, Mo M, Yamazaki T, Okumura Y, Hirayama A; J’xactly Investigators. Hisatake S, et al. Among authors: yamashita t. Circ Rep. 2022 Sep 13;4(10):490-498. doi: 10.1253/circrep.CR-22-0082. eCollection 2022 Oct 7. Circ Rep. 2022. PMID: 36304427 Free PMC article.
Investigation of the optimal treatment strategy for atrial fibrillation in Japan.
Yamashita T, Ogawa S, Aizawa Y, Atarashi H, Inoue H, Ohe T, Okumura K, Kato T, Kamakura S, Kumagai K, Kurachi Y, Kodama I, Koretsune Y, Saikawa T, Sakurai M, Sugi K, Nakaya H, Nakayama T, Hirai M, Fukatani M, Mitamura H, Yamazaki T; J-RHYTHM Investigators. Yamashita T, et al. Circ J. 2003 Sep;67(9):738-41. doi: 10.1253/circj.67.738. Circ J. 2003. PMID: 12939546 Free article. Clinical Trial.
Randomized study of angiotensin II type 1 receptor blocker vs dihydropiridine calcium antagonist for the treatment of paroxysmal atrial fibrillation in patients with hypertension.
Yamashita T, Ogawa S, Aizawa Y, Atarashi H, Inoue H, Ohe T, Okumura K, Ohtsu H, Kato T, Kamakura S, Kumagai K, Kurachi Y, Kodama I, Koretsune Y, Saikawa T, Sakurai M, Sugi K, Nakaya H, Hirai M, Hirayama A, Fukatani M, Mitamura H, Yamazaki T, Watanabe E; J-RHYTHM II Investigators. Yamashita T, et al. Circ J. 2006 Oct;70(10):1318-21. doi: 10.1253/circj.70.1318. Circ J. 2006. PMID: 16998266 Free article. Clinical Trial.
Optimal treatment strategy for patients with paroxysmal atrial fibrillation: J-RHYTHM Study.
Ogawa S, Yamashita T, Yamazaki T, Aizawa Y, Atarashi H, Inoue H, Ohe T, Ohtsu H, Okumura K, Katoh T, Kamakura S, Kumagai K, Kurachi Y, Kodama I, Koretsune Y, Saikawa T, Sakurai M, Sugi K, Tabuchi T, Nakaya H, Nakayama T, Hirai M, Fukatani M, Mitamura H; J-RHYTHM Investigators. Ogawa S, et al. Among authors: yamashita t. Circ J. 2009 Feb;73(2):242-8. doi: 10.1253/circj.cj-08-0608. Epub 2008 Dec 8. Circ J. 2009. PMID: 19060419 Free article. Clinical Trial.
Body size and atrial fibrillation in Japanese outpatients.
Suzuki S, Yamashita T, Ohtsuka T, Sagara K, Uejima T, Oikawa Y, Yajima J, Koike A, Nagashima K, Kirigaya H, Ogasawara K, Sawada H, Yamazaki T, Aizawa T. Suzuki S, et al. Among authors: yamashita t. Circ J. 2010 Jan;74(1):66-70. doi: 10.1253/circj.cj-09-0431. Epub 2009 Oct 2. Circ J. 2010. PMID: 19797821 Free article.
Impact of drug alteration to maintain rhythm control in paroxysmal atrial fibrillation. - Subanalysis from J-RHYTHM study -.
Endo A, Kohsaka S, Suzuki S, Atarashi H, Kamakura S, Sakurai M, Nakaya H, Fukatani M, Mitamura H, Yamazaki T, Yamashita T, Ogawa S; J-RHYTHM Investigators. Endo A, et al. Among authors: yamashita t. Circ J. 2010 May;74(5):870-5. doi: 10.1253/circj.cj-09-0643. Epub 2010 Apr 3. Circ J. 2010. PMID: 20379004 Free article. Clinical Trial.
Randomized trial of angiotensin II-receptor blocker vs. dihydropiridine calcium channel blocker in the treatment of paroxysmal atrial fibrillation with hypertension (J-RHYTHM II study).
Yamashita T, Inoue H, Okumura K, Kodama I, Aizawa Y, Atarashi H, Ohe T, Ohtsu H, Kato T, Kamakura S, Kumagai K, Kurachi Y, Koretsune Y, Saikawa T, Sakurai M, Sato T, Sugi K, Nakaya H, Hirai M, Hirayama A, Fukatani M, Mitamura H, Yamazaki T, Watanabe E, Ogawa S; J-RHYTHM II Investigators. Yamashita T, et al. Europace. 2011 Apr;13(4):473-9. doi: 10.1093/europace/euq439. Epub 2010 Dec 10. Europace. 2011. PMID: 21148662 Clinical Trial.
Statin treatment for patients with paroxysmal atrial fibrillation.
Watanabe E, Yamashita T, Suzuki S, Saikawa T, Hirai M, Yamazaki T, Ohtsu H, Ogawa S; J-RHYTHM Investigators. Watanabe E, et al. Among authors: yamashita t. Int Heart J. 2011;52(2):103-6. doi: 10.1536/ihj.52.103. Int Heart J. 2011. PMID: 21483169 Free article. Clinical Trial.
Echocardiographic predictors of frequency of paroxysmal atrial fibrillation (AF) and its progression to persistent AF in hypertensive patients with paroxysmal AF: results from the Japanese Rhythm Management Trial II for Atrial Fibrillation (J-RHYTHM II Study).
Suzuki T, Yamazaki T, Ogawa S, Nagai R, Yamashita T; J-RHYTHM II Investigators. Suzuki T, et al. Among authors: yamashita t. Heart Rhythm. 2011 Dec;8(12):1831-6. doi: 10.1016/j.hrthm.2011.07.035. Epub 2011 Aug 2. Heart Rhythm. 2011. PMID: 21816128 Clinical Trial.
6,940 results